Longitudinal Dynamics of Skin Bacterial Communities in the Context of Staphylococcus aureus Decolonization.
Staphylococcus aureus
decolonization
households
microbiome
skin
Journal
Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614
Informations de publication
Date de publication:
27 04 2022
27 04 2022
Historique:
pubmed:
7
4
2022
medline:
30
4
2022
entrez:
6
4
2022
Statut:
ppublish
Résumé
Decolonization with topical antimicrobials is frequently prescribed in health care and community settings to prevent Staphylococcus aureus infection. However, effects on commensal skin microbial communities remains largely unexplored. Within a household affected by recurrent methicillin-resistant S. aureus skin and soft tissue infections (SSTI), skin swabs were collected from the anterior nares, axillae, and inguinal folds of 14 participants at 1- to 3-month intervals over 24 months. Four household members experienced SSTI during the first 12-months (observational period) and were prescribed a 5-day decolonization regimen with intranasal mupirocin and bleach water baths at the 12-month study visit. We sequenced the 16S rRNA gene V1-V2 region and compared bacterial community characteristics between the pre- and post-intervention periods and between younger and older subjects. The median Shannon diversity index was stable during the 12-month observational period at all three body sites. Bacterial community characteristics (diversity, stability, and taxonomic composition) varied with age. Among all household members, not exclusively among the four performing decolonization, diversity was unstable throughout the year post-intervention. In the month after decolonization, bacterial communities were changed. Although communities largely returned to their baseline states, relative abundance of some taxa remained changed throughout the year following decolonization (e.g., more abundant
Identifiants
pubmed: 35384711
doi: 10.1128/spectrum.02672-21
pmc: PMC9045213
doi:
Substances chimiques
Anti-Bacterial Agents
0
Anti-Infective Agents, Local
0
RNA, Ribosomal, 16S
0
Water
059QF0KO0R
Mupirocin
D0GX863OA5
Chlorhexidine
R4KO0DY52L
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0267221Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR002345
Pays : United States
Références
Cochrane Database Syst Rev. 2008 Oct 08;(4):CD006216
pubmed: 18843708
Science. 2014 Aug 29;345(6200):1048-52
pubmed: 25170151
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4554-61
pubmed: 20847294
Future Microbiol. 2013 Feb;8(2):209-22
pubmed: 23374126
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28630195
N Engl J Med. 2019 Feb 14;380(7):638-650
pubmed: 30763195
N Engl J Med. 2013 Jun 13;368(24):2255-65
pubmed: 23718152
Cell. 2016 May 5;165(4):854-66
pubmed: 27153496
Antimicrob Agents Chemother. 2016 Nov 21;60(12):7303-7312
pubmed: 27671074
JAMA Pediatr. 2020 Jun 1;174(6):552-562
pubmed: 32227144
Am J Infect Control. 2016 Jul 1;44(7):830-6
pubmed: 26905790
Clin Infect Dis. 2011 Feb 1;52(3):e18-55
pubmed: 21208910
Appl Environ Microbiol. 2013 Sep;79(17):5112-20
pubmed: 23793624
Br J Dermatol. 2008 Mar;158(3):442-55
pubmed: 18275522
Pediatr Res. 2018 Nov;84(5):668-676
pubmed: 30135590
JAMA. 2020 Jan 28;323(4):319-328
pubmed: 31886828
Cell Host Microbe. 2013 Dec 11;14(6):631-40
pubmed: 24331461
Pediatrics. 2008 Jun;121(6):1090-8
pubmed: 18519477
Lancet Infect Dis. 2020 Feb;20(2):188-198
pubmed: 31784369
Appl Environ Microbiol. 2009 Dec;75(23):7537-41
pubmed: 19801464
Clin Infect Dis. 2005 Jun 15;40(12):1785-91
pubmed: 15909267
Am J Infect Control. 2015 Jun;43(6):640-3
pubmed: 25798778
Clin Infect Dis. 2021 Dec 6;73(11):e4568-e4577
pubmed: 32521007
Surg Infect (Larchmt). 2010 Feb;11(1):49-57
pubmed: 19788383
Genome Med. 2012 Oct 10;4(10):77
pubmed: 23050952
Clin Infect Dis. 2012 Mar;54(6):743-51
pubmed: 22198793
Lancet. 2013 Mar 30;381(9872):1099-106
pubmed: 23363666
Cell Host Microbe. 2011 Oct 20;10(4):311-23
pubmed: 22018232
Elife. 2013 Apr 16;2:e00458
pubmed: 23599893
PLoS One. 2010 May 17;5(5):e10598
pubmed: 20498722
PLoS One. 2008 Jul 23;3(7):e2719
pubmed: 18648509
J Invest Dermatol. 2018 Oct;138(10):2234-2243
pubmed: 29753031
Infect Control Hosp Epidemiol. 2011 Sep;32(9):872-80
pubmed: 21828967
Eur J Clin Microbiol Infect Dis. 2015 May;34(5):999-1004
pubmed: 25604707
Genome Biol. 2011 Jun 24;12(6):R60
pubmed: 21702898
Cold Spring Harb Perspect Med. 2013 Dec 01;3(12):a015362
pubmed: 24296350
J Infect. 2019 Mar;78(3):200-207
pubmed: 30503843
Genome Res. 2012 May;22(5):850-9
pubmed: 22310478
J Perinatol. 2019 Jan;39(1):63-71
pubmed: 30237474
N Engl J Med. 2002 Jun 13;346(24):1871-7
pubmed: 12063371
Sci Transl Med. 2017 Feb 22;9(378):
pubmed: 28228596
Clin Infect Dis. 2012 Mar 1;54(5):707-13
pubmed: 22157322
Diagn Microbiol Infect Dis. 2017 May;88(1):53-57
pubmed: 28215714
Antimicrob Agents Chemother. 2007 Oct;51(10):3591-8
pubmed: 17682105
PLoS One. 2021 Jun 8;16(6):e0252004
pubmed: 34101737